DH1: An Analysis of the Impact of Medication Non-Adherence and Type of Medication on Outcome Domains Using the SCAP Health Questionnaire (English)
- New search for: Russo, P.
- New search for: Dirani, R.
- New search for: Russo, P.
- New search for: Dirani, R.
In:
VALUE IN HEALTH
;
3
, 2
;
52
;
2000
-
ISSN:
- Article (Journal) / Print
-
Title:DH1: An Analysis of the Impact of Medication Non-Adherence and Type of Medication on Outcome Domains Using the SCAP Health Questionnaire
-
Contributors:Russo, P. ( author ) / Dirani, R. ( author )
-
Published in:VALUE IN HEALTH ; 3, 2 ; 52
-
Publisher:
- New search for: VALUE IN HEALTH
-
Publication date:2000-01-01
-
Size:52 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 3, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 49
-
D2: Cost Utility of Docetaxel vs Vinorelbine or Paclitaxel in Advanced Breast CancerBrown, R. / Hutton, J. et al. | 2000
- 49
-
D1: Development and Validation of a Screening Instrument for Gastroesophageal Reflux DiseaseFullerton, S. / Emery, K. / Reyes, E. / Lee, J. / Shaw, M. / Shafiroff, J. / Willian, M. K. / Grogg, A. / Sadik, K. / Ofman, J. et al. | 2000
- 49
-
D3: A Pharmacoeconomic Model to Assess the Cost-Effectiveness of Trovafloxacin Compared to Ceftazidime for Nosocomial Pneumonia in a Public Hospital Setting in Hong KongLee, K. K. C. / You, J. H. S. / Ho, S. S. S. / Chan, T. Y. K. et al. | 2000
- 50
-
R1: Quantifying the Impact of Interactions Between HMG-COA Reductase Inhibitors (Stains) and Cytochrome P-450 Interacting Drugs on Healthcare Utilization: A Population-Based StudyIskedjian, M. / Metege, C. J. / Einarson, T. R. / Yogendran, M. / Mukherjee, J. et al. | 2000
- 50
-
D4: Economic Analysis of Warfarin in Outpatients with Atrial Fibrillation: Innovator Versus GenericMittman, N. / Bartle, W. / Walker, S. E. / Oh, P. I. et al. | 2000
- 51
-
R3: Donepezil Use and Impact on Cost Among Patients with Alzheimer's DiseaseWest, W. A. / Prashker, M. / Merriman, L. / Anderson, J. / Miller, D. et al. | 2000
- 51
-
R4: Availability of Highly Active Antiretroviral Therapy Associated with Increased Survival and Lower Costs at a VA Medical CenterMcCollum, M. / Malone, D. C. / MacWhinney, S. / Bessesen, M. et al. | 2000
- 51
-
R2: Risk Factors for Short-Term Diabetes Complications: An Analysis of Linked Administrative Claims and Clinical Laboratory DataMenzin, J. / Boulanger, L. / Friedman, M. / Langley-Hawthorne, C. / Cavanaugh, R. et al. | 2000
- 52
-
DH1: An Analysis of the Impact of Medication Non-Adherence and Type of Medication on Outcome Domains Using the SCAP Health QuestionnaireRusso, P. / Dirani, R. et al. | 2000
- 52
-
DH3: Public Report Spurs Hospital Mortality ReductionCzerwinski, A. A. / Horgan, M. M. et al. | 2000
- 52
-
DH2: Medicare's Extended Immunosuppression Coverage Improved Middle-Income Renal Graft SurvivalWoodward, R. S. / Schnitzler, M. A. / Hollenbeak, C. S. / Lowell, J. A. / Singer, G. G. / Cohen, D. S. / Spitznagel, E. L. / Brennan, D. C. et al. | 2000
- 53
-
Q1: Consumer and Staff Validation of a Self-Administered Health-Related Quality of Life Instrument for Individuals with SchizophreniaBarr, J. T. / Schumacher, G. E. / Mason, E. J. / Ohman, S. M. / Hanson, A. et al. | 2000
- 53
-
DH4: Schizophrenic Care and Assessment Program (SCAP): Impact of Clinical and Functional Status and Type of Medication Treatment on Outpatient Psychiatric UtilizationRusso, P. / Dirani, R. / Smith, M. et al. | 2000
- 54
-
Q2: Patient Preferences for Treatment Outcomes in Disabling TremorLeidy, N. K. / Palmer, C. / Coughlin, C. / Halpern, M. / Charles, D. et al. | 2000
- 54
-
Q3: Health-Related Quality of Life (HRQOL) in African American Men with Prostate Cancer: Data from CaPSURELubeck, D. P. / Grossfeld, G. / Ray, P. / Flanders, S. C. / Carroll, P. R. et al. | 2000
- 54
-
Q4: Minimum Meaningful Difference Scores for the Irritable Bowel Syndrome Quality of Life Questionnaire (IBSQOL)Watson, M. E. et al. | 2000
- 55
-
ICP2: The Relative Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) and Tricyclic Antidepressants (TCAs) in Reducing Worker AbsenteeismTreglia, M. / Neslusan, C. et al. | 2000
- 55
-
ICP1: Incorporating Measurement of Indirect Costs in the Evaluation of an Asthma Health Management ProgramErshoff, D. H. / Buchner, D. A. et al. | 2000
- 56
-
ICP3: Factors Influencing Patient Willingness to Pay for Diabetes Disease State Management ProgramsBarner, J. C. et al. | 2000
- 56
-
ICP4: Health State Preferences in Diabetic Peripheral NeuropathyDevine, E. B. / Sullivan, S. D. / Lew, D. P. / Veenstra, D. L. et al. | 2000
- 56
-
CAN1: Comparison of Cost of Asthma Treatment Between Patients Treated with Anti-Inflammatories Versus BronchodilatorsHuse, D. M. / Russell, M. W. / Weiss, S. T. / Hartz, S. C. et al. | 2000
- 57
-
CAN3: Baseline Cost of Illness of Parkinson's Disease in a Large Healthcare PlanHeaton, A. H. / Martin, S. L. / Littlefield, R. S. et al. | 2000
- 57
-
CAN2: Shorter Hospital Length of Stay for Coronary Angioplasty Patients Who Receive Abciximab Versus Eptifibatide or TirofibanLage, M. J. / Barber, B. L. / Scherer, J. / McCollam, P. et al. | 2000
- 58
-
CEB2: Cost-Effectiveness of Meningococcal Vaccine in the UKBrown, R. E. / Sorensen, S. / Batista, C. / Nuijten, M. et al. | 2000
- 58
-
CAN4: Is Prior Community Antibiotic Treatment of Patients Hospitalised with Lower Respiratory Tract Infection Associated with Reduced In-Hospital Mortality and Length of Stay?Steinke, D. / Donnan, P. / MacDonald, T. / Davey, P. et al. | 2000
- 58
-
CEB1: Pharmacogenomics: Evaluating the Economic ImpactVeenstra, D. L. / Higashi, M. K. et al. | 2000
- 59
-
DUC1: Drug Utilization of Cisapride and Contraindicated Drugs in a US Managed Care PopulationGuo, J. J. / Jones, J. K. / Fife, D. / Curkendall, S. / Goehring, E. / She, D. et al. | 2000
- 59
-
CEB3: Cost-Effectiveness of Prevention of Coronary Heart Disease (CHD) with Simvastatin in PolandKuzniar, J. / Orlewska, E. / Hermanowski, T. / Romandzuk, W. / Splawinski, J. et al. | 2000
- 59
-
CEB4: The Cost-Effectiveness of Fixed-Dose Combination of Diclofenac and Misoprostol in Prevention of NSAID-Induced Ulcers in Rheumatoid Arthritis Patients in PolandOrlewska, E. et al. | 2000
- 60
-
DUC2: Insurance Claims Costs for Overactive Bladder in AdultsZhou, Z. / Jensen, G. A. et al. | 2000
- 60
-
DUC3: Smoking Cessation Success Rates with Drug Therapy in a Sample of Medicaid PatientsFincham, J. E. / Braman, K. S. / McNees, G. E. et al. | 2000
- 61
-
DUC4: High Users of beta~2-Agonists: Are Medicaid Recipients Being Treated According to National Asthma Guidelines?Reddy, P. / Kelly, E. / Kophazi, M. / Geary, E. / Markelon, J. / Welter, K. et al. | 2000
- 61
-
MI1: Identifying Factors Associated with High and Low Cost Asthmatics: Opportunities for Disease Management Using Automatic Interaction DetectionBoscarino, J. A. / Zhao, Z. / Andrews, K. W. / Sokol, M. C. / Yao, J. / McGuigan, K. A. / Gutierrez, B. / Refowitz, R. et al. | 2000
- 61
-
MI2: The Number Needed to Treat Approach: Evaluating the Clinical Relevance of Fexofenadine in Seasonal Allergic RhinitisCrawford, B. / Marquis, P. / Offord, S. et al. | 2000
- 62
-
MI4: A Framework for Cost-Effectiveness Analysis from Clinical Trial DataO'Hagan, A. / Stevens, J. W. et al. | 2000
- 62
-
MI3: Reliability and Validity of International Prostate Symptome Score (I-PSS) for Early Assessment of Symptoms in the Treatment of Benign Prostate Hyperplasia (BPH)Singh, A. / Ashraf, T. / Verlinden, M. H. et al. | 2000
- 63
-
S2: Use of Estrogen Replacement Therapy in Maryland Medicaid FemalesHuang, X. / Weiss, S. R. / Zuckerman, I. H. / Hsu, V. D. et al. | 2000
- 63
-
S3: Statistical Method for Modeling Dual Selection Bias: Woodwork Effect and Drug Selection Bias Among Multiple AlternativesShi, L. / McCombs, J. S. et al. | 2000
- 63
-
S1: Impact of Community-Acquired Pneumonia Treatment Guidelines on Length of Stay and CostMerchant, S. V. / Mullins, C. D. / Cooke, C. E. et al. | 2000
- 64
-
BT2: Direct Costs of Obesity in PortugalPereira, J. / Mateus, C. / Amaral, M. J. et al. | 2000
- 64
-
S4: Methods for Comparing Areas Under Receiver Operating Characteristic Curves: Application in Screening Accuracy for DepressionShaw, J. W. / Treglia, M. / Motheral, B. / Coons, S. J. et al. | 2000
- 64
-
BT1: Postoperative Pain Severity After Abdominal or Orthopedic Surgery: Interim ResultsStrassels, S. / Chen, C. / Carr, D. / McDonagh, M. / Gouveia, W. / Wurm, H. et al. | 2000
- 65
-
BT4: Cost-Effectiveness of High Versus Low Dose Angiotensin Converting Enzyme Inhibitors (ACEIs) in the Treatment of Chronic Heart Failure (CHF): An Economic Analysis of the US Assessment of Treatment with Lisinopril and Survival (ATLAS) TrialSchwartz, J. S. / Wang, Y. / Cleland, J. et al. | 2000
- 65
-
BT3: The Comparative Economic Value of Raltitrexed and 5-FU Plus LeucovorinSimons, W. R. / Grace, E. M. et al. | 2000
- 66
-
CEB6: The IMportance of Comparable Patient Populations in Cost-Effectiveness Analyses: Tolterodine Versus Oxybutinin XL for Treating Overactive BladderSchonfeld, W. H. / Sheriff, S. K. / Levaux, H. P. / Williamson, T. E. et al. | 2000
- 66
-
CEB5: Measuring Patient Preferences Using Conjoint Analysis: A New ApproachPhillips, K. A. / O'Brien, B. / Skolnik, H. / Johnson, T. R. et al. | 2000
- 66
-
CEB7: Socioeconomic Efficiency of the Adjuvant Treatment with Acamprostate in Maintaining Abstinenance in Alcohol Dependent PatientsKilburg, A. / Daniel, D. / Pfeil, T. / Kirchoff, D. / Rychilk, R. et al. | 2000
- 67
-
PCD1: Incorporating Both Diastolic and Systolic Pressures in a Model of the Benefits of Achieving Hypertension Treatment TargetsHuse, D. M. / Russell, M. W. / Usry, C. A. / Hartz, S. C. et al. | 2000
- 67
-
CEB8: A Decision Analytic Model Measuring the Cost-Effectiveness of Highly Active Antiretroviral Therapy (HAART) in HIV + Patients with High Versus Low Baseline Viral Load: An Indinavir Plus Lamivudine and Zidovudine ExampleRisebrough, N. A. / Oh, P. / Rachlis, A. / McMurchy, D. / Bast, M. / Doswell, M. et al. | 2000
- 68
-
PCD3: Incidence, Utilization of Health Care and Costs of StrokeWilson, L. / Le, K. / Nguyen, C. / Tam, A. / Le, S. et al. | 2000
- 68
-
PCD4: The Impact of Secondary Events on the Cost of Acute Myocardial InfarctionO'Brien, J. / Pierce, D. / Caro, J. et al. | 2000
- 68
-
PCD2: Assessing the Burden of Illness in Elderly Versus Younger Acute Coronary Syndrome PatientsEisenstein, E. L. / Peterson, E. D. / Shaw, L. K. / Hasselblad, V. / Nelson, C. L. / Hakim, Z. / Mark, D. B. et al. | 2000
- 69
-
PCD5: Costs of Left Ventricular Assist Device Versus Positive Inotropic Therapy as a Bridge to Heart TransplantStanek, E. J. / Loh, E. et al. | 2000
- 69
-
PCD7: Socioeconomic Evaluation of Cilostazol for the Secondary Prevention of Cerebral Infarction in JapanKobayashi, M. / Gotah, F. et al. | 2000
- 69
-
PCD6: Cost Analysis of Antihypertensive Drug Use in TurkeySapci, H. / Bozkurt, E. / Durlu, T. / Kandilci, B. / Ozsogut, B. / Demirdamar, R. / Akalin, K. / Mutlugil, A. et al. | 2000
- 70
-
PCD10: Impact of New Statin Doses on Market SegmentationMiller, J. D. / Russell, M. W. / Huse, D. M. / Hartz, S. C. et al. | 2000
- 70
-
PCD8: A Model Comparing Nitroglycerin Formulations for Acute Angina Episodes: Assessing the Economic IssuesBell, C. F. / Semroc, G. N. / Stephens, J. M. / Klingman, D. / Dever, M. T. et al. | 2000
- 70
-
PCD9: Cost-Effectiveness of Ramipril in Hypertensive Patients with Nephropathy in GermanySchadlich, P. K. / Brecht, J. G. / Huppertz, E. et al. | 2000
- 71
-
PCD12: Spironolactone in Heart Failure: Life and Cost Saving Treatment in PolandKuzniar, J. / Orlewska, E. / Splawinski, J. et al. | 2000
- 71
-
PCD13: Cost-Effectiveness Analysis of Enalapril in the Management of CHF in PolandOrlewska, E. / Kuzniar, J. / Romanczuk, W. / Splawinski, J. et al. | 2000
- 71
-
PCD11: The Cost-Effectiveness Analysis as a Substantiation of Diagnostic and Treatment of Early Stage of Heart FailureGorokhova, S. G. / Vorobiev, P. A. et al. | 2000
- 72
-
PCD14: Treatment Cost of Side Effects of Antiarrhythmic Drugs in the USABhattacharyya, S. K. / Morrato, E. H. et al. | 2000
- 72
-
PCD15: How Meaningful Are the Coronary Benefits of Selective Estrogen Receptor Modulators?Russell, M. W. / Huse, D. M. / Miller, J. D. / Hartz, S. C. et al. | 2000
- 73
-
PCD16: Cost-Effectiveness of Tirofiban Plus Heparin as Compared with Heparin Only in Treating Unstable AnginaShi, L. / Hay, J. et al. | 2000
- 73
-
PCD17: The Effects of Payor Status on Procedure Use and Outcomes of Patients with Congestive Heart FailureKroch, E. / Loh, E. / Schwartz, J. S. / Shah, R. / Fisher, D. et al. | 2000
- 73
-
PCD18: The Perceptual Effectiveness Index: A New Approach for Evaluating Outcomes of Anti-Hypertensive TherapyLeidy, N. K. / Flynn, J. / Zyczynski, T. M. et al. | 2000
- 74
-
PCD21: Two-Year Medication Compliance in Patients with Acute Myocardial InfarctionPlante, M. / Gupta, A. / Bruckman, D. / Mehta, R. / Eagle, K. et al. | 2000
- 74
-
PCD20: Estimating the Effects of Polypharmacy on Hospitalization in an Elderly CHF Medicaid PopulationBramley, T. / Dickson, M. / Rowen, R. et al. | 2000
- 74
-
PCD19: Relationship Between Daily Dose Frequency and Adherence to Antihypertensive Pharmacotherapy: Update of a Meta-AnalysisIskedjian, M. / Einarson, T. R. et al. | 2000
- 75
-
PCD23: Unadjusted Inpatient Costs and Mortality for Four Cerebrovascular Events for Patients Treated at Community Teaching and Nonteaching HospitalsReed, S. D. / Jarvik, J. G. / Meyer, K. E. et al. | 2000
- 75
-
PCD22: The Effect of Nationality on Health-Related Quality of Life in the Gusto-I Angiographic TrialCoyne, K. / Hill, M. / Allen, J. / Kim, M. / Chandra, N. / Ross, A. et al. | 2000
- 76
-
PCD26: A Closer Look at Hypertension Practice Patterns and Medication ComplianceGuico-Pabia, C. J. / Campbell, R. F. / Dedeker, K. / Sheffeld, R. / Moravec, R. / Wertheimer, A. L. et al. | 2000
- 76
-
PCD24: Conjoint Analysis Comparing Preferences for Treatment Outcomes in Heart Failure and Healthy Patients: Longevity Versus Symptom ReliefOates, M. B. / Stanek, E. J. / McGhan, W. F. / DeNofrio, D. / Loh, E. et al. | 2000
- 76
-
PCD25: Systematic Review Evidence on Treating Hypertension in Older AdultsMcDonagh, M. / Bradley, M. / Shirley, A. / Kleijnen, J. et al. | 2000
- 77
-
PMH1: Recent Trends in the Cost of Care for Patients with SchizophreniaJohnstone, B. M. / Loosbrock, D. L. / Stockwell Morris, L. / Gibson, J. P. / Barber, B. L. / Lichtenstein, M. / Henderson, S. / Dulisse, B. K. et al. | 2000
- 77
-
PMH2: Estimated Costs of Treatment for Bipolar Affective Disorder in a Large Employer DatabaseJohnstone, B. M. / Loosbrock, D. L. / Stockwell Morris, L. / Gibson, J. P. / Barber, B. L. / Lichtenstein, M. / Henderson, S. / Dulisse, B. K. et al. | 2000
- 78
-
PMH4: Antipsychotic Medication Treatment Patterns and Associated Cost of Care of Patients with SchizophreniaLoosbrock, D. L. / Johnstone, B. M. / Stockwell Morris, L. / Gibson, P. J. / Barber, B. L. / Lichtenstein, M. S. / Henderson, S. C. / Dulisse, B. K. et al. | 2000
- 78
-
PMH3: Alzheimer's Disease Cost of Care in Managed CareRichards, K. M. / Shepherd, M. D. / Crismon, M. L. / Snyder, E. H. et al. | 2000
- 79
-
PMH6: Pharmacoeconomic Analyses of Depot Neuroleptic Treatment in Natural SettingGurovich, I. / Kobina, S. / Lyubov, E. / Litvischenko, Y. / Shmukler, A. et al. | 2000
- 79
-
PMH7: Cost-Effectiveness of Atypical Antipsychotics in Chronic SchizophreniaKarki, S. D. / Bellnier, T. J. / Hager, E. P. et al. | 2000
- 79
-
PMH5: The Effect of Rivastigmine on the Direct and Indirect Costs of Alzheimer's DiseaseBrooks, E. / Deal, L. et al. | 2000
- 80
-
PMH9: A Managed Care Validation Program for a Pharmacoeconomic Model of Major DepressionCasciano, J. / Arikian, S. / Doyle, J. J. / Casciano, R. et al. | 2000
- 80
-
PMH8: Cost-Effectiveness of Stratified Care in the Management of MigraineRapoport, A. / Lipton, R. B. / Williams, P. / Sawyer, J. et al. | 2000
- 80
-
PMH10: A Model to Perform Economic Evaluations of Interventions for Acute Muscular Low Back PainNeighbors, D. / Earnshaw, S. R. / Bell, L. / Bhattacharyya, S. K. et al. | 2000
- 81
-
PMH11: Treatment Guidelines Compared to Clinical Practice for Acute Muscular Low Back PainEarnshaw, S. R. / Neighbors, D. / Bell, L. / Bhattacharyya, S. K. et al. | 2000
- 81
-
PMH12: The Efficiency of Drug Treatment in First Episode Schizophrenia: Treatment Guidelines in the UKDavies, L. M. / Lewis, S. et al. | 2000
- 82
-
PMH15: Utilization of Antipsychotic Medications in the Treatment of Schizophrenia in a Managed Care PopulationNichol, M. B. / Harada, A. S. M. / Jones, J. P. / McCombs, J. S. / Grogg, A. / Gilderman, A. / Vaccaro, J. et al. | 2000
- 82
-
PMH13: Withdrawn| 2000
- 82
-
PMH14: Use of Olanzapine and Risperidone at Baseline in a Prospective Study of the Course of Treatment for SchizophreniaJohnstone, B. M. / Dulisse, B. K. / Loosbrock, D. L. / Gibson, P. J. et al. | 2000
- 83
-
PMH17: Bipolar Disorder Drug Use Patterns and Compliance in Medi-Cal PopulationLi, J. / McCombs, J. / Stimmel, G. et al. | 2000
- 83
-
PMH18: Use of Nonbarbiturate Sedative/Hypnotic Agents in an Ambulatory PopulationHornquist, M. / Carlson, A. / Morris, L. et al. | 2000
- 83
-
PMH16: Use of Atypical Antipsychotic Medications in a Veterans PopulationHudson, T. / Feng, W. / Owen, R. / Austen, M. et al. | 2000
- 84
-
PMH19: Antipsychotic Drug Use Patterns and the Cost of Treating Schizophrenia: Data from the Medicaid Programs of Alabama, Georgia, Kentucky, and MichiganLyu, R. R. / McCombs, J. S. / Johnstone, B. M. / Muse, D. N. et al. | 2000
- 84
-
PMH20: Medical Resources Consumption by Patients with Chronic and Breathrough PainNoe, L. / Peeples, P. et al. | 2000
- 85
-
PMH21: Community Pharmacist Assessment of the Quality of Life of Treated Ambulatory Depressed PatientsTaylor, A. T. / Longe, R. L. / Spruill, W. J. / Wade, W. E. / Wagner, P. J. et al. | 2000
- 85
-
PMH23: How Much Change in Quality of Life and Symptom Scores Represents a Detectable Difference for Schizophrenia Patients?Cramer, J. A. / Rosenheck, R. et al. | 2000
- 85
-
PMH22: Can the Brief "QOLWM" Discriminate Among Migraineurs in the Community?Cramer, J. A. / Silberstein, S. / Winner, P. / Chmiel, J. / Noble, K. et al. | 2000
- 86
-
PMH24: Translations of the Migraine Specific Quality of Life Questionnaire (MSQ): A Psychometric Comparison Between the English, Finnish, Dutch, Hungarian, and Spanish TranslationsGrossman, P. R. / Black, L. K. / Kwong, J. et al. | 2000
- 86
-
PMH25: The Impact of Schizophrenia on Health-Related Quality of Life (HRQL) for Patients Admitted to Psychiatric Units of General Acute Care HospitalsDurkin, M. B. / Edell, W. S. / Mody, S. H. / Adams, B. E. / Repp, E. A. et al. | 2000
- 86
-
PMH26: Change in Health-Related Quality of Life in Patients with Schizophrenia Taking Antipsychotic AgentsEdell, W. S. / Durkin, M. B. / Mody, S. H. / Adams, B. E. / White, R. E. / Qiu, A. Z. et al. | 2000
- 87
-
PMH28: Quality of Life Differences Between Patients with Episodic and Transformed MigraineMeletiche, D. M. / Lofland, J. H. / Young, W. B. / Hopkins, M. M. et al. | 2000
- 87
-
PMH27: The Impact of Depression on Health-Related Quality of Life (HRQL)Mody, S. H. / Edell, W. S. / Durkin, M. B. / Adams, B. E. / Repp, E. A. et al. | 2000
- 88
-
PMH31: Treatment of Childhood Depression in a Managed Care PopulationMcLaughlin, T. / Yazdani, C. / Hansen, J. / Margraf, T. et al. | 2000
- 88
-
PMH29: The Impact of an Over-The-Counter Migraine Medication on Patient Quality of LifeBurk, C. / Nicho, M. B. / Wu, Q. / Gilderman, A. / Salas, J. et al. | 2000
- 88
-
PMH30: Modeling Length of Prescription Therapy for Depression PatientsBillingsley, J.-K. / Nichols, J. L. et al. | 2000
- 89
-
PMH32: Quantifying the Economic Impact of Potential Drug Interactions in the Treatment of DepressionBourne, M. J. / Prescott, J. D. / Baumann, J. A. / Mayo, K. W. / Bailey, K. L. et al. | 2000
- 89
-
PMH33: Neuroleptic Drug Exposure and Tardive Dyskinesia: A Records-Based Case-Control StudyMarshall, D. L. / Hazlet, T. K. / Gardner, J. S. / Blough, D. K. et al. | 2000
- 90
-
PMH35: Economic Outcomes with Newer Antidepressants for the Treatment of Depression in a Commercially-Insured PopulationMukherjee, R. / Lian, J. / Hines, P. / Dezii, C. / Chen, S. / Scull, R. / Alter, C. et al. | 2000
- 90
-
PMH34: Characterization and Assessment of Depression in a Chronic Non-Malignant Pain Population Using Two Different Methodologies in a Claims DatabaseMody, S. H. / Hsu, A. Y. / Dodd, S. L. et al. | 2000
- 90
-
PMH36: Conformance with Antipsychotic Drug Therapy Guidelines for Treating Schizophrenia in the California Medicaid (Medi-Cal) ProgramLuo, M. / McCombs, J. S. / Shi, L. / Stimmell, G. L. et al. | 2000
- 91
-
PMH38: Response to Nefazodone, Cbasp, and Combined Therapy: Implications for Chronic Depression Severity, Functional Status and Economic OutcomesCrown, W. H. / Berndt, E. / Finkelstein, S. / Russell, J. / Ling, D. / White, A. / Koran, L. / Dunner, D. / Kocsis, J. / Kornstein, S. et al. | 2000
- 91
-
PMH37: Evaluating Healthcare Resource Utilization in a Population of Migraine Patients Using Sumatriptan and Non-Sumatriptan PharmaceuticalsJoish, V. N. / Cady, P. S. / Culbertson, V. L. / Delate, T. et al. | 2000
- 92
-
PMH41: Patterns of Antidepressant Use and Concomitant Psychotherapeutic AgentsFulop, G. / Bona, J. R. / Brookler, R. / Nemeroff, C. B. et al. | 2000
- 92
-
PMH39: Health Care Burden and Cost of Parkinson's DiseaseWilson, L. / Huang, J. / Doshi, D. et al. | 2000
- 92
-
PMH40: Access to New Medications to Treat SchizophreniaMark, T. / Dirani, R. / Russo, P. et al. | 2000
- 93
-
POS1: The Burden of Osteoporosis to the State of Florida: Projections for 2000-2010Burge, R. T. / Worley, D. et al. | 2000
- 93
-
PMH42: The Impact of Adding SSRI Antidepressants to the Medicaid Formulary in CaliforniaMcCombs, J. S. / Shi, L. / Stimmel, G. et al. | 2000
- 94
-
POS2: Interest of the Simple Calculated Osteoporosis Risk Estimatinon (SCORE) Tool for a More Rational Use of Bone DensitometryBenSedrine, W. / Devogelaer, J. P. / Kaufman, J. M. / Goemaere, S. / Depresseux, G. / Bruyere, O. / Reginster, J. Y. et al. | 2000
- 94
-
POS3: The Simple Calculated Osteoporosis Risk Estimation (SCORE) Does Not Allow Identification of Belgian Women with a High Risk of OsteoporosisBenSedrine, W. / Devogelaer, J. P. / Kaufman, J. M. / Goemaere, S. / Depresseux, G. / Bruyere, O. / Reginster, J. Y. et al. | 2000
- 95
-
POS4: Cost-Effectiveness of Screening for Osteoporosis in Elderly WomenDu, H. V. / Hay, J. et al. | 2000
- 95
-
POS5: Prevalence of Pharmacotherapy for the Treatment and Prevention of Osteoporosis in a Managed Care EnvironmentHall, J. / Nelson, M. et al. | 2000
- 95
-
PAR1: The Burden of Early Rheumatoid Arthritis on Health Related Quality of LifeKosinski, M. / Wanke, L. A. / Buatti, M. C. et al. | 2000
- 96
-
PAR3: Reduced Utilization of Antiulcerant Drugs with Celecoxib: Findings of the Painless TrialCastaldo, R. S. / Luke, D. R. / Grisanti, M. W. / Kalmuk, E. / Palazzo, R. G. / LaDuca, R. L. et al. | 2000
- 96
-
PAR2: Pharmacoeconomical Analysis of Non-Steroid Anti-Inflammatory Drugs in RheumatologyNasonova, V. A. / Vorobjov, P. A. / Tsvetkova, E. S. / Avksentieva, M. V. et al. | 2000
- 97
-
PAR5: Comparing the Health Related Quality of Life Outcomes of Treatment for Early Rheumatoid ArthritisBury-Maynard, D. / Kosinski, M. / Wanke, L. A. / Buatti, M. C. et al. | 2000
- 97
-
PAR4: NSAID Utilization Among Commercially Insured Members in a Managed Care EnvironmentHall, J. / Clouse, J. et al. | 2000
- 97
-
PAR6: Quality of Life Measurements as Predictors of Change in Therapy in Patients with Musculoskeletal DisordersYazdani, C. / Cox, E. R. / Castro, W. L. et al. | 2000
- 98
-
PMW1: The Need for a Quality-of-Life Instrument for Erectile Dysfunction: A Systematic Review of the LiteratureLenderking, W. R. / Sweeney, S. L. / Pashos, C. L. / Flanders, S. C. et al. | 2000
- 98
-
PAR7: The Longterm Safety and Effectiveness of Cyclosporine in Patients with Severe Rheumatoid Arthritis (RA)Marra, C. A. / Guh, D. / Fisher, J. H. / Chalmers, A. / Esdaile, J. / Anis, A. H. et al. | 2000
- 98
-
PMW2: Does Testosterone Affect Health-Related Quality of Life in Healthy, Elderly Males?- A Pilot StudyReddy, P. / White, C. M. / Dunn, A. B. / Moyna, N. M. / Thompson, P. D. et al. | 2000
- 99
-
PMW4: Measurement Properties of Quality of Life Instruments in Erectile Dysfunction (ED): A Review of Published ResultsEmery, M. P. / Kunle, A. / Marquis, P. / Sagnier, P. P. / Kubin, M. et al. | 2000
- 99
-
PMW3: Prescription Drug Use During Pregnancy: A Claims AnalysisZenk, H. A. / Carlson, A. et al. | 2000
- 100
-
PMW5: A Pharmacoeconomic Evaluation of Hormone Replacement Therapy in the United Kingdom and BelgiumDoyle, J. J. / Arikian, S. / Casciano, J. / Casciano, R. / Baleeva, J. / Gonzalez, M. A. et al. | 2000
- 100
-
PMW6: Matching VA Urologists' Preferences in the Management of Benign Prostatic Hyperplasia with Clinical Practice GuidelinesFernandes, A. W. / Amonkar, M. M. / Madhavan, S. / Nseyo, U. O. et al. | 2000
- 100
-
PMT1: The Value of Observational Datasets in the Economic Evaluation of Pharmaceuticals: UK ObservationsTolley, K. / Pang, F. / Brown, M. et al. | 2000
- 101
-
PMT3: Predicting Drug Spending: Update and Evaluation of a Revised Chronic Disease ScoreZhao, Z. / Boscarino, J. A. / Deverka, P. A. / Epstein, R. S. / Wang Chin, J. et al. | 2000
- 101
-
PMT2: Reliability of Prescription Claims Data for Health Care ResearchThomas, J. / Hutchins, D. S. / Fehr, A. F. / Mitrany, D. et al. | 2000
- 102
-
PMT4: Methodological Issues in Estimating Disease Progression: Is Markov Model the Best Method?Shih, Y. C. / Ke, X. T. et al. | 2000
- 102
-
PMT5: Development of Multi-Language Patient Outcome AssessmentsRentz, A. M. / Trudeau, E. / Schmier, J. K. / Dubois, D. / Jones, R. / Marquis, P. / Willian, M. K. / Revicki, D. A. et al. | 2000
- 103
-
PMT7: The French Health Utilities Index Mark 3Le Gales, C. / Buron, C. / Costet, N. / Rosman, S. / Slama, G. et al. | 2000
- 103
-
PMT8: Development of a New Scoring of the Women's Health Questionnarie (WHQ)Girod, I. / Keininger, D. / de la Loge, C. / Hunter, M. et al. | 2000
- 103
-
PMT6: Monitoring the Gatekeeper: Methodologies for the Development of Process and Outcome Measures for the Evaluation of IRBSGold, K. F. et al. | 2000
- 104
-
PMT9: Assessing the Cost-Effectiveness Ratio of a New Anti-Platelet Agent: Methodologic IssuesLevy, E. / Gabriel, S. / Dinet, J. / Carita, P. et al. | 2000
- 104
-
PMT10: Modelling Issues: First Episode SchizophreniaDavies, L. M. / Lewis, S. et al. | 2000
- 104
-
PMT11: Methodology for Identifying Patients at High Risk for Osteoporotic Fractures Within a Managed Care EnvironmentHeaton, A. H. / Littlefield, R. S. / Martin, S. L. et al. | 2000
- 105
-
PMT13: Transfering the Results from Economic Evaluations: The Use of Baxiliximab in Transplant PatientsLee, K. M. / Coyle, D. / Baladi, J. F. et al. | 2000
- 105
-
PMT12: Data Requirements Of Second-Generation Economic Models In HIV/AIDSSimpson, K. N. / Voit, E. O. / Hutton, J. / Sun, E. / Ashraf, T. et al. | 2000
- 106
-
PMT15: Validation of Framingham Regression Equations for Local UseMilne, R. J. et al. | 2000
- 106
-
PMT14: Improving the Evidence Base of Economic AnalysesCoyle, D. / Lee, K. M. et al. | 2000
- 106
-
PMT16: Estimation of Annual Cardiovascular Risk in PilotsMilne, R. J. et al. | 2000
- 107
-
PMT18: Bias Arising from Missing Data in a Retrospective Study of the Outcomes of Intra-Abdominal InfectionsDavey, P. / Libby, G. / Hunter, K. / Broomhall, J. / Kosteridis, D. / Steinke, D. / Yin, D. et al. | 2000
- 107
-
PMT17: Dealing with Skewed Data: An Example Using Asthma-Related Costs of Medicaid ClientsRascati, K. L. / Smith, M. J. et al. | 2000
- 107
-
PMT19: Non-Randomized Studies Comparing Olanzapine and Risperidone: Baseline Similarities and DifferencesGibson, P. J. / Loosbrock, D. L. et al. | 2000
- 108
-
PMT20: The Use of Economic Analyses in Practice Guideline DevelopmentWallace, J. F. / Ofman, J. J. / Hohlbauch, A. A. / Lewensztain, L. S. / Richards, M. S. / Henning, J. M. / Weingarten, S. R. et al. | 2000
- 108
-
PMT22: Treatment Satisfaction in Outcomes Research: An Overview of Study MeasuresWang, A. Y. / Graham, L. A. / Copley-Merriman, C. et al. | 2000
- 108
-
PMT21: Deriving Health Utilities from Efficacy Outcome Scales in Alzheimer's Disease (AD)Lanctot, K. L. / Oh, P. I. / Risebrough, N. / Mazzotta, P. et al. | 2000
- 109
-
PMT23: Monte-Carlo Simulation as an Alternative Technique in Addressing the Unit Cost Variability IssueTran, G. / McKenna, M. / Kennedy, L. / Pang, F. et al. | 2000
- 109
-
PMT24: "Camouflaged Sampling" Using BC Ministry of Health Data: A Method of Recruiting Subjects While Preserving Data PrivacyMaclure, M. / Lynd, L. D. / Warren, L. D. / Pare, P. D. / Anis, A. H. et al. | 2000
- 110
-
PMT26: Fieller's Interval, Its Extensions and Their Applications in Cost-Effectiveness AnalysesJiang, G. J. / Williams, G. R. / Wu, J. et al. | 2000
- 110
-
PMT25: Comparative Econometric Models of Medical CostsWu, Q. / Hay, J. W. et al. | 2000
- 111
-
PMT30: Preference Based Index from the SF-12Sengupta, N. / Nichol, M. B. / Globe, D. et al. | 2000
- 111
-
PMT29: The Influence of Statistical Errors on the Cost-Effectiveness of Treatments Following a Phase-III Clinical TrialKamae, I. / Yanagisawa, S. et al. | 2000
- 111
-
PMT28: Health Related Quality of Life in a General Swedish Population with a Gender PerspectiveLundberg, L. / Bardage, C. / Johannesson, M. / Bingefors, K. / Isacsor, D. et al. | 2000
- 112
-
PMT32: Utility Estimation Using the EQ-5D: Expert Panel Data and Alternative Methods of SynthesisSmith, D. / Davies, L. / Manca, A. / Kind, P. et al. | 2000
- 112
-
PMT31: An Assessment of Cost-Utility of Patients from SF-36 Scores Using the Beaver Dam Health Outcomes Study MethodNadesan, B. / Cady, P. / Culbertson, V. et al. | 2000
- 113
-
PMT34: Assessing Physician Practice Profitability Using an Activity Based Costing ModelStephens, J. M. / Bell, C. F. / Klingman, D. et al. | 2000
- 113
-
PMT33: Linguistic Validation of the Vascular Quality of Life Questionnaire (VASCUQOL) in 8 LanguagesConway, K. / Uzun, V. / Girod, I. / Morgan, M. / Koch, P. et al. | 2000
- 113
-
PMT35: Valuing Non-Workplace Productivity Lost in Migraineurs: Human Capital Approach and Replacement Cost MethodKim, S. S. / Lofland, J. H. et al. | 2000
- 114
-
PMT37: Benefits of Early Modeling in Drug DiscoveryStevenson, M. / Bryant-Comstock, L. / Brennan, A. et al. | 2000
- 114
-
PMT36: Linguistic Validation of the Work Limitations Questionnaire (WLQ)Conway, K. / Mear, I. / Touzet, L. / Lerner, D. / Bresnahan, B. / Martens, L. et al. | 2000
- 114
-
PWP1: Comparative Burden of Illness at Two Large US CompaniesWogen, S. / Birnbaum, H. G. / Greenberg, P. E. / Holland, M. D. / Deverka, P. / Epstein, R. et al. | 2000
- 115
-
PWP3: Consumer Preferences for Dental Anesthesia: Putting Your Money Where Your Mouth IsMatthews, D. / Rocchi, A. / Garni, A. et al. | 2000
- 115
-
PWP2: A Methodology to Measure Productivity of Health Outcomes GroupsSesti, A. M. / Abright, J. / McLaughlin-Miley, C. / Copley-Merriman, C. et al. | 2000
- 116
-
PWP4: A Willingness-to-Pay Assessment of Two Treatments for ObesityTrakas, K. / Oh, P. I. / Shear, N. H. et al. | 2000
- 116
-
PWP6: A Preliminary Study of Provision of Pharmaceutical Care in Community Pharmacy in Singapore: Cost Analysis & Patient Willingness to PayLi, S. C. / Chan, S. Y. / How, P. P. et al. | 2000
- 116
-
PWP5: Work Productivity Effects of Diabetes: Implications for Research and PolicyLavigne, J. E. et al. | 2000
- 117
-
PHV2: The Burden of Respiratory Synctial Virus (RSV) Hospitalizations in the USHoward, T. S. / Stang, P. E. et al. | 2000
- 117
-
PHV1: Utilization of Intensive Care and Hospital Days and Outcome in Patients with Severe Sepsis: The Select II RegistryFormica, C. A. / Drabinski, A. / Kim, S. / Williams, G. R. et al. | 2000
- 117
-
PHV3: Modelling a Cost-of-Illness Study to Evaluate the Burden of Influenza in ItalyAimola, A. / Gianfrate, F. et al. | 2000
- 118
-
PHV4: Health Care Utilization and Costs Associated with Four Categories of Skin Ulcers in New Mexico Medicaid PatientsKumar, R. N. / Gupchup, G. V. / Dodd, M. / Iskedjian, M. / Einarson, T. R. / Raisch, D. W. et al. | 2000
- 118
-
PHV5: Effectiveness and Costs of Antibiotics in the Ambulatory Treatment of Respiratory Tract InfectionsLaurier, C. / Lachaine, J. / Manzi, P. et al. | 2000
- 119
-
PHV8: Uncomplicated Acute Pyelonephritis in Adult Women: Inpatient Versus Outpatient Therapy - Economic ComparisonTibi-Levy, Y. / Elkharrat, D. / de Pouvourville, G. et al. | 2000
- 119
-
PHV7: Managing Pneumocystosis: The Cost of Hospitalization in the USO'Brien, J. / Pierce, D. / Caro, J. et al. | 2000
- 119
-
PHV6: Economic Evaluation of a Safety Device for Subcutaneous Injections of Low Molecular Weight Heparin (LMWH)Durand-Zaleski, I. / Gabriel, S. / Dinet, J. et al. | 2000
- 120
-
PHV10: A Preliminary Study: The Pharmacoeconomic Profile of Antibiotic Use in TurkeySapci, H. / Bozkurt, E. / Durlu, T. / Kandilci, B. / Ozsogut, B. / Demirdamar, R. et al. | 2000
- 120
-
PHV9: Cost of Treating Hispanic Patients with AIDS in US HospitalsO'Brien, J. / Pierce, D. / Jackson-Kelley, H. / Caro, J. et al. | 2000
- 120
-
PHV11: Cost-Minimization Analysis of Azithromycin IV/PO Versus Cefuroxime IV/PO +/-Erythromycin IV/PO for Community-Acquired PneumoniaWong, A. H. / Phillips, E. / Tailor, S. A. / Cornish, W. / Shear, N. H. / Lavoie, F. et al. | 2000
- 121
-
PHV13: Cost Analysis of Ceftriaxone Versus Ceftriaxone Plus Macrolide Treatment for Patients Hospitalized with Community-Acquired Pneumonia (CAP)Truong, K. / Kucukarslan, S. / Ailani, R. / Wright, D. / DiGiovine, B. et al. | 2000
- 121
-
PHV12: Management Strategies for Ribavirin-Induced Hemolytic Anemia in the Treatment of Hepatitis C: Clinical and Economic ImplicationsDevine, E. B. / Kowdley, K. V. / Sullivan, S. D. / Veenstra, D. L. et al. | 2000
- 121
-
PHV14: A Multinational Pharmacoeconomic Evaluation of the Seven-Valent Pneumococcal Conjugate VaccineArikian, S. / Ciuryla, V. / Doyle, J. J. / Casciano, J. / Casciano, R. / Hvidsten, K. et al. | 2000
- 122
-
PHV15: Clinical and Economic Benefits of the Pneumococcal Conjugate Vaccine in ChildrenOster, G. / Weycker, D. / Ciuryla, V. / Richardson, E. / Thompson, D. et al. | 2000
- 122
-
PHV16: An Unusual Economic Evaluation of Efavirenz Compared to IndinavirMigliaccio-Walle, K. / Raggio, G. / O'Brien, J. / Caro, J. et al. | 2000
- 122
-
PHV17: Preliminary Assessment of the Economic Value of Adult Pertussis Booster VaccinationBotteman, M. F. / Pashos, C. L. / Staginnus, U. et al. | 2000
- 123
-
PHV18: Safety-Net Hospital Perspective: Cost-Effectiveness of Treatment for Hepatitis CSinger, M. E. et al. | 2000
- 123
-
PHV19: Impact of Antibiotic Choice on Costs, Outpatient Visits, and 28-Day Outcomes for Community-Acquired Pneumonia PatientsBell, T. J. / Mauskopf, J. A. / Gallagher, K. M. / L'Italien, G. J. / Anton, S. et al. | 2000
- 124
-
PHV22: Utilization and Cost-Effectiveness of Antimicrobials in Community-Acquired PneumoniaKarpov, O. / Zaytsev, A. et al. | 2000
- 124
-
PHV20: Cost-Effectiveness Analysis of Lamivudine Treatment in Chronic Hepatitis BYeh, Y. C. / Biddle, A. K. / Hartzema, A. G. et al. | 2000
- 124
-
PHV21: Preliminary Assessment of the Economic Value of Pertussis Booster Vaccination of Hospital StaffBotteman, M. F. / Pashos, C. L. / Staginnus, U. et al. | 2000
- 125
-
PHV25: Quality of Life of Adult Patients Treated for a Respiratory Tract InfectionLachaine, J. / Laurier, C. / Manzi, P. et al. | 2000
- 125
-
PHV23: Patient Adherence with Multi-Drug HIV Therapy: Variations in Adherence and Correlation with HIV RNA LevelsFarmer, K. C. / Rathbun, C. / Clay, P. / Stephens, J. / Bui, T. / Slater, L. et al. | 2000
- 125
-
PHV24: Discriminative Ability of the SF-12 in a Sample of Persons with HIVDelate, T. / Coons, S. J. et al. | 2000
- 126
-
PHV26: Effectiveness of Antibiotic Prescribing and Patient Outcomes in a Community Setting: The Australian ExperienceBeilby, J. / Marley, J. / Walker, D. / Chamberlain, N. / Lydick, E. / Hess, G. / Burke, M. et al. | 2000
- 126
-
PHV27: Costs and Outcomes of Treating Febrile Neutropenia in Nine European CountriesFlynn, J. / Elixhauser, A. / Constenla, D. / Baleva, J. / Ciuryla, V. et al. | 2000
- 127
-
PHV28: Withdrawn| 2000
- 127
-
PHV29: Variability in the Criteria for Early Switch and Early Discharge in Community-Acquired Pneumonia: A Systematic Review of the LiteratureRhew, D. C. / Tu, G. S. / Ofman, J. / Henning, J. M. / Richards, M. S. / Weingarten, S. R. et al. | 2000
- 127
-
PHV30: Costs and Outcomes of a Respiratory Syncytial Virus Prophylaxis Program in a Medicaid Managed Care OrganizationSchaffer, M. / Amaya, M. A. / Vojta, D. et al. | 2000
- 128
-
PHV31: Withdrawn| 2000
- 128
-
PCN1: Outcomes and Costs of Acute Myeloid Leukemia Over One Year Following Diagnosis: An Analysis of Seer-Medicare DataMenzin, J. / Lang, K. / Earle, C. E. / Kerney, D. et al. | 2000
- 129
-
PCN3: Predictors of Cervical Cancer Inpatient Admission Costs by StageBerg, G. D. / Chattopadhyay, S. K. et al. | 2000
- 129
-
PCN4: Application of Pharmacoeconomics and Outcomes Research on Decision-Making Patterns by Medical OncologistsSarpong, D. F. / Jamero, D. J. / Ball, C. K. et al. | 2000
- 129
-
PCN2: Withdrawn| 2000
- 130
-
PCN7: Cost-Effectiveness of Rituximab in Relapsed, Refractory, Low-Grade Non-Hodgkin's LymphomaCattaneo, M. J. / Nichol, M. B. et al. | 2000
- 130
-
PCN5: Cost-Effectiveness of Early Detection and Prevention of Colorectal Cancer by Screening with Fecal Occult Blood TestsParson, R. E. / Baker, J. T. et al. | 2000
- 130
-
PCN6: Cost-Effectiveness of Genetic Testing in Hereditary Non-Polyposis Colorectal CancerHenderson, L. B. / Scheuner, M. T. / Ofman, J. J. et al. | 2000
- 131
-
PCN8: Pharmacoeconomics of Combination of Chemotherapy with Docetaxel in Advanced Breast CancerPoddubnaya, I. V. / Arkadyeva, T. V. / Kobina, S. A. et al. | 2000
- 131
-
PCN9: Patterns of Epoetin Alpha Utilization in Anemic Cancer PatientsScott, W. G. / Arbuckle, R. B. / McCormick, W. / Sansgiry, S. S. et al. | 2000
- 132
-
PCN10: Psychometric Validity of Quality of Life and Utility Measures in Non-Small Cell Lung Cancer (NSCLC): A Literature ReviewEmery, M. P. / Adesina, K. / Marquis, P. / Van Gool, R. et al. | 2000
- 132
-
PCN11: Symptomatic Anemia During Cancer Chemotherapy: rhErythropoietin (rhEPO) and Quality of LifeBonicatto, S. / Giacomi, N. / Ferreras, R. / De la Cruz, J. / Cichetti, G. / Gelemur, M. / Riva, M. / Ivulich, C. / Ferreyra, L. et al. | 2000
- 132
-
PCN12: Racial Differences in the Cost of Treating Early Stage Prostate CancerBrandeis, J. / Pashos, C. L. / Henning, J. M. / Litwin, M. S. et al. | 2000
- 133
-
PCN13: Colonoscopy Charges in a Managed Care Population: Differences Based on Polypectomy and Malignancy StatusGandhi, S. K. / Mehta, S. S. / McLaughlin, T. / Okamoto, L. / Boyer, J. G. et al. | 2000
- 133
-
PCN14: Effectiveness of Erythropoietin in Cancer PatientsMorris, C. / Halberg, D. L. / McIntyre, W. J. et al. | 2000
- 134
-
PCN15: Cost-Effectiveness of Tamoxifen in Breast Cancer Risk ReductionSengupta, N. / Hay, J. W. et al. | 2000
- 134
-
PCN16: Validity of the Time-Trade Off Technique in Determining Preferences for the Treatment of Prostate CancerWatkins Bruner, D. / Baron, J. et al. | 2000
- 134
-
PCN17: Convenience is the Main Reason Why Ovarian Cancer Patients Prefer Oral RegimenCalhoun, B. A. / Roland, P. Y. et al. | 2000
- 135
-
PDB1: Resource Use and Cost Associated with Micro- and Macrovascular Complications in Patients with Type 2 DiabetesGoertz, A. / Spannheimer, A. / Reitberger, U. / Liebl, A. / Neiss, A. et al. | 2000
- 135
-
PDB2: The Effects of Age and Complications on the Cost of Managing Members with Type 1 Diabetes MellitusMartinson, M. S. / Liao, E. / Newell, J. A. et al. | 2000
- 136
-
PDB4: Cost-Effectiveness of Diabetic Foot Ulcer Treatment with Autologous Platelet ReleasateKantor, J. / Margolis, D. J. et al. | 2000
- 136
-
PDB5: Cost-Effectiveness of Rentinopathy Screening in Pediatric Patients with Type I Diabetes MellitusLi, J. / Hay, J. et al. | 2000
- 136
-
PDB3: The Effects of Age and Complications on the Cost of Managing Members with Type 2 Diabetes MellitusMartinson, M. S. / Liao, E. / Newell, J. A. et al. | 2000
- 137
-
PDB7: Treatment Costs of Type-2 Diabetes Mellitus Patients with and without Selected Cardiovascular ComorbiditiesBhattacharyya, S. K. / Else, B. A. et al. | 2000
- 137
-
PDB6: Evaluation of Clinical and Demographic Factors Associated with Diabetic Foot Ulcer Treatment CostsWade, S. W. / Kadlubek, P. J. / Fastenau, J. M. / Gause, D. / Thomasson, J. / Goldberg, G. A. et al. | 2000
- 138
-
PDB8: Health Related Quality of Life (HRQOL) Measures in Type 2 DiabetesChang, J. / Guo, A. / Rodriguez, J. / Chen, Y. / McNulty, P. / Martens, L. et al. | 2000
- 138
-
PDB10: Economic Outcomes of HMG CoA Reductase Inhibitors in a Hypertensive Diabetic Population in a Managed Care OrganizationWhite, T. J. / Juzba, M. / Berenbeim, D. M. / Gilderman, A. M. / Salas, J. C. et al. | 2000
- 138
-
PDB9: Cost of Concomitant Illnesses Among Patients with Hypertension and DiabetesFarquhar, I. V. / Jackson, J. D. / Weir, E. et al. | 2000
- 139
-
PDB11: Evaluation of a Diabetes Disease Management Program in a Nursing HomeLonge, R. L. / Wagner, P. J. et al. | 2000
- 139
-
PRN1: Overactive Bladder Cost of Illness: Analysis of Medi-Cal ClaimsBailey, K. L. / Torigoe, Y. / Zhou, S. / Mo, L. S. / Flewelling, S. L. et al. | 2000
- 140
-
PRN2: Cost-Effectiveness of Basiliximab, Daclizumab, and OKT3 as Induction Agents in Kidney TransplantationShin, G. P. / Johnson, N. / Vasquez, E. / Walton, S. et al. | 2000
- 140
-
PRN3: Cost Analysis of "Optimal" US Dialysis Modality UtilizationJust, P. M. / Mendelssohn, D. C. / Mehta, R. L. et al. | 2000
- 140
-
PRN4: Assessing Quality of Life in Routine Clinical Practice: A Pilot Study in Patients with Renal DiseaseWild, D. / Grove, A. / Keogh, A. / Farina, C. et al. | 2000
- 141
-
PRN6: Developing a Specific HRQL Instrument for Overactive BladderCoyne, K. / Schmier, J. / Hunt, T. / Corey, R. / Liberman, J. / Revicki, D. et al. | 2000
- 141
-
PRN7: Reliability of Reporting on Coping Strategies and Impact of Overactive BladderStewart, W. F. / Hunt, T. / Payne, C. K. et al. | 2000
- 141
-
PRN5: Quality of Life and Health Care Resource Utilization in Overactive Bladder Patients with Urge IncontinenceRosner, A. J. / Becker, D. L. / Borrie, M. J. / Hobbs, C. / Fedorkow, D. M. / Vallely, J. F. / King, H. J. / Turpie, I. et al. | 2000
- 142
-
PRN8: Medical Care of Overactive Bladder in Elderly Medicare PatientsJensen, G. A. / Zhou, Z. / Torigoe, Y. et al. | 2000
- 142
-
PRN9: The Influence of Pharmaceutical Care Services on the Blood Pressure of Renal Transplant PatientsChisholm, M. A. / Vollenweider, L. J. / Martin, B. C. / Mulloy, L. / Jagadeesan, M. / DiPiro, J. T. et al. | 2000
- 143
-
PRS2: Impact of a Targeted Asthma Intervention Program on Treatment CostsSuh, D. C. / Shin, S. K. / Voytovich, R. M. / Okpara, I. / Zimmerman, A. et al. | 2000
- 143
-
PRS3: Trends in the Use of beta-Agonist Medications in British Columbia: An Analysis of BC Pharmacare DataLynd, L. D. / Raboud, J. / Guh, D. / Pare, P. D. / Anis, A. H. et al. | 2000
- 143
-
PRS1: Direct and Indirect Costs of Asthma to an EmployerBirnbaum, H. G. / Greenberg, P. E. / Wanke, L. A. / Atkins, K. et al. | 2000
- 144
-
PRS6: Classifying Asthma Severity Based on Prescription Drug ClaimsLeahy, M. J. / Klingman, D. / Bell, C. F. et al. | 2000
- 144
-
PRS5: Impact of Inhaled Corticosteroids (Fluticasone Propionate) on Economic Outcomes in a Managed Care EnvironmentOates, V. / Vaziri, B. / Ober, J. / Gothard, L. et al. | 2000
- 144
-
PRS4: Identifying Predictors of the Asthma-Specific Quality of Life Questionnaire for Native-American Adults (AQLQ-NAA)Gupchup, G. V. / Kumar, R. N. / Tonrey, L. / Riley, K. et al. | 2000
- 145
-
PRS8: Economic Outcomes of Steroid Inhaler Use Patterns in a Managed Care OrganizationWhite, T. J. / Juzba, M. / Berenbeim, D. M. / Gilderman, A. M. / Salas, J. C. et al. | 2000
- 145
-
PRS7: Drivers of Diagnosis of Obstructive Lung Disease, by Stage of SeveritySilberman, C. / Lally, C. / Lydick, E. et al. | 2000
- 146
-
PRS9: Predictors of Hospitalization and Emergency Room Use in a Medicaid Managed Care Asthmatic PopulationDrabinski, A. M. / Schaffer, M. / Chatterton, M. L. et al. | 2000
- 146
-
PRS10: Annual Cost of Treating Asthma in a Managed Care PopulationYazdani, C. / Stanford, R. / McLaughlin, T. / Margraf, T. et al. | 2000
- 146
-
PSG1: Inpatient Utilization of Medical Services Associated with Peripheral Arterial Disease-Related Inpatient Procedures in the Department of DefenseZachry, W. M. / Shepherd, M. D. / Wilson, J. P. et al. | 2000
- 147
-
PSG4: Traumatic Colon Injuries: Difference in Hospital Costs by Type of Surgical RepairO'Brien, J. / Pierce, D. / Jacobs, L. et al. | 2000
- 147
-
PSG2: Ten-Year Costs Associated with Peripheral Arterial Disease-Related Inpatient Procedures in the Department of DefenseZachry, W. M. / Shepherd, M. D. / Wilson, J. P. / Lawson, K. A. et al. | 2000
- 147
-
PSG3: Costs Incurred During Inpatient Admission for Common Surgeries: Preliminary ResultsStrassels, S. / Chen, C. / Carr, D. / McDonagh, M. / Gouveia, W. / Wurm, H. et al. | 2000
- 148
-
PSG6: Cost-Minimization Analysis of Epoetin Alpha in the Community HospitalSantorello, J. G. et al. | 2000
- 148
-
PSG5: The Economic Impact of the Use of Perfluoro-N-Octane During Retinal Detachment SurgeryVenkataraman, K. S. / Barnes, J. R. / Scott, I. U. et al. | 2000
- 149
-
PSG9: Clinical and Economic Outcomes of Coronary Angioplasty Alone or in Combination with Stents in Academic Health Centers: A Retrospective Database AnalysisOinonen, M. J. / Akhras, K. S. / Chen, C. / Matuszewski, K. A. / Vlasses, P. H. et al. | 2000
- 149
-
PSG7: Postoperative Pain Relief, Interference with Activities, and Satisfaction: Preliminary ResultsStrassels, S. / Chen, C. / Carr, D. / McDonagh, M. / Gouveia, W. / Wurm, H. et al. | 2000
- 149
-
PSG8: Long-Term Outcomes and Resource Use Associated with MyomectomySubramanian, S. / Clark, M. A. / Quinn, V. C. et al. | 2000
- 150
-
PSG11: Cost Analysis of Inhaled Agents in Canadian Pediatric HospitalsBussieres, J. F. / Giguere, M. et al. | 2000
- 150
-
PSG10: Restenosis and Medical Costs Following Percutaneous Transluminal Coronary Angioplasty (PTCA) with and without StentSen, S. / Khandker, R. / Roth, D. / Thomas, J. et al. | 2000
- 150
-
PSG12: Hospital Cost Savings from Severity-Adjusted Length of Stay Following Surgery for Intra-Abdominal Infection and Treatment with Piperacillin/Tazobactam or Impipenem/CilastatinBjerke, S. / Mallick, R. / Clark, K. / Wible, M. / Zito, E. / Guttman, R. / Sillup, G. et al. | 2000
- 151
-
PSG14: Cost-Effective Strategies: Assessing Pharmacists Intervention in a Community Hospital Intensive Care UnitDilanchian, P. / Sansgiry, S. S. et al. | 2000
- 151
-
PSG13: Prophylaxis of Postoperative Nausea and Vomiting: Testing the Value of a Dolasetron-Based AlgorithmDarkow, T. / Harper, M. L. / Goulson, D. T. et al. | 2000
- 152
-
PGD3: Prospective Evaluation of an Information Dissemination Program Incorporating Peer Comparison Feedback in Peptic Ulcer Disease ManagementDennett, S. L. / Thomas, J. / Sen, S. / Bernard, P. G. / Cramer, S. / Schumacher, J. / Lang, J. et al. | 2000
- 152
-
PGD2: Improved Drug Compliance Using Education Affects Medical Utilization and Quality of Life for Peptic Ulcer Disease PatientsAddiego, J. / Berger, J. / McStay, P. / Craig, R. / O'Leary, W. / Slezak, J. / Schwaab, M. / Hasan, E. / Apolinski, L. et al. | 2000
- 152
-
PGD1: Over-the-Counter NSAID Use and GI ToxicityBloom, B. S. / Straus, W. L. / Thomas, J. / Berger, M. I. et al. | 2000
- 153
-
PGD4: The Clinical and Economic Impact of Competing Management Strategies for Gastroesophageal Reflux Disease (GERD)Ofman, J. / Fennerty, M. B. / Dorn, G. / Fass, R. et al. | 2000
- 153
-
PDH1: Economic Implications for Safety-Net Hospitals: Screening for Hepatitis CSinger, M. E. et al. | 2000
- 153
-
PDH2: Factors Related to Prescription Drug Expenditure Growth: Volume vs. PriceChawla, A. J. / Dubois, R. W. / Neslusan, C. A. / Smith, M. S. / Wade, S. W. et al. | 2000
- 154
-
PDH4: Technology Assessment in the US: What Do Payers Understand and What Information Do They Want?Evans, C. / Crawford, B. / Dukes, E. et al. | 2000
- 154
-
PDH3: Pharmaceutical Price Controls and Positive Drug List Effects on Total and Social Insurance ExpendituresKarokis, A. / Christodoulopoulou, A. / Tsiaras, T. / Mossialos, E. et al. | 2000
- 155
-
PDH7: The Impact of Locus of Control on ComplianceReed, P. / Gourley, G. / Herrier, R. / Gourley, D. et al. | 2000
- 155
-
PDH5: Health Care Expenditure in an HMO Before and After an Exclusive Pharmacy PartnershipPeris, A. / Castiglione, B. / Vanscoy, G. J. et al. | 2000
- 155
-
PDH6: Advantages and Limits of the French Hospital Database (PMSI) on Description of Haemophilia Management and CostsJasso-Mosqueda, J. G. / Omnes, L. F. / Gomez, E. / Losa, N. / Chicoye, A. / Durand-Zaleski, I. et al. | 2000
- 156
-
PDH10: Potential Value for Money of Research: Beta Interferon and the UK-MS StudyDavies, L. / Smith, D. et al. | 2000
- 156
-
PDH8: Subspecialists: Do They Provide Better Quality and More Efficient Care? An Analysis of Outcomes Data from 6 HospitalsWeingarten, S. R. / Lloyd, L. E. / Braunstein, G. D. et al. | 2000
- 156
-
PDH9: Drug and Examination in Relation to the Total Therapy Costs-a Cost Management Dilemma?Schmelzer, A. / Klask, J. / Losch, M. et al. | 2000
- 157
-
PDH11: Evaluation of Cigarette Smokers' Perceptions of Smoking Cessation and the Role of Health Care ProfessionalsDodd, M. A. / Gupchup, G. V. et al. | 2000
- 157
-
PDH12: A Randomized Controlled Multi-Center Study Evaluating the Effect of Pharmaceutical Care on Changes in Quality of LifeMalone, D. C. / Carter, B. L. / Billups, S. J. / Ellis, S. et al. | 2000
- 158
-
PDH13: Quality of Care Inferences from Multivariate Analysis of Ambulatory DataKroch, E. / Brailer, D. et al. | 2000
- 158
-
PDH15: Withdrawn| 2000
- 158
-
PDH14: Compliance and Persistency Benefits Achieved by Utilizing a Once Daily Extended Release Medication vs. a Twice Daily RegimenDezii, C. M. / Kawabata, H. / Tran, M. et al. | 2000
- 159
-
PDH17: Are the British Government's Healthcare Reforms Targeting Patients' Needs?: Evidence from a Comparison of Two GP Surveys on Musculoskeletal CareDickson, D. J. / Hosie, G. / English, J. / Dickson, A. J. et al. | 2000
- 159
-
PDH18: Enter the Dragon: Pharmacoeconomics in AsiaPang, F. / Tran, G. et al. | 2000
- 159
-
PDH16: Identifying Patients with Psychoses in a Medicaid Managed Care Organization with Carved-Out Behavioral Health ServicesBachleda, M. J. / Moxey, E. / Goldfarb, N. / Schaffer, M. et al. | 2000
- 160
-
PDH19: Analysis of the Total Cost and Resources Consumed in Cases of Single and Concurrent Chronic IllnessGaris, R. I. / Farmer, K. C. / Jacobs, E. W. et al. | 2000
- 161
-
PDH22: Modelling the Benefits of Verteporfin Therapy in Macular DegenerationSmith, D. / Fenn, P. / Drummond, M. et al. | 2000
- 161
-
PDH20: Content Analysis of Pharmacoeconomic Advertising in Specialty and Primary Care JournalsSullivan, P. W. / Hirsch, J. D. / Nichol, M. B. / Conner, C. / Teratanaut, R. et al. | 2000
- 161
-
PDH21: Pre-Post and Between Group Differences in Patient Outcomes in a Pharmaceutical Care Intervention ProjectKamath, T. V. / Chaikledkaew, U. / Johnson, K. A. et al. | 2000
- 162
-
PDH23: Relevance of Pharmacoeconomics and Health Outcomes Information to Health Care Decision-Makers in the United StatesCox, E. / Motheral, B. / Griffis, D. et al. | 2000
- 162
-
PDH24: Pharmaceutical Industry Perceptions of the Use of Pharmacoeconomic Data by Health Care OrganizationsArmstrong, E. P. / Abarca, J. / Motheral, B. R. / Grizzle, A. J. et al. | 2000
- 162
-
PDH25: A Qualitative Assessment of Managed Care Decision-Makers' Views and Use of Pharmacoeconomic InformationGrizzle, A. / Motheral, B. / Garrity, B. / Cox, E. / Armstrong, E. et al. | 2000
- 163
-
PDH26: A National Survey of Decision-Makers in Managed Care on Their Views and Use of Pharmacoeconomic InformationMotheral, B. / Grizzle, A. / Armstrong, E. / Cox, E. / Bataoel, J. / Bennett, D. / Shahriar, J. et al. | 2000
- 163
-
PDH27: The Satisfaction and Economic Evaluation of Converting a Traditional Hospital System Using a Unit Dose System, at a Hospital in Barbados, West IndiesGriffith, J. A. / Lai, L. et al. | 2000
- 164
-
PDH29: Factors Affecting Asthmatic, Diabetic, and Hypertensive Patient Self-Reported Compliance in a Pharmaceutical Care Demonstration ProjectChaikledkaew, U. / Kamath, T. / Johnson, K. A. et al. | 2000
- 164
-
PDH30: Role of HRQL Evaluation in the Drug Regulatory Process: Preliminary Results from a European Regulatory SurveyAcquadro, C. et al. | 2000
- 164
-
PDH28: A Drug Cost Model for a Capitated Patient Population Within an Integrated Health Care SystemPatel, R. P. / Petitta, A. / Andrews, M. J. et al. | 2000
- 165
-
PDH31: Health Related Quality of Life and Regulatory Issues: Comparison of US and European InitiativesMarquis, P. / Abetz, L. / Acquadro, C. et al. | 2000
- 165
-
PDH33: Evaluation and Treatment of Short Stature: National Cooperative Growth Study (NCGS) ExperienceBlethen, S. L. et al. | 2000
- 165
-
PDH32: Cost Impact of a Prescription Benefit Change in a Medicare Managed Care PlanBalkrishnan, R. / Byerly, W. G. et al. | 2000